News

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
It’s usually a sign of a digestive issue, but other conditions can cause yellow diarrhea, too. If you frequently experience ...
A compelling naturopathic case study by Dr. Eric Dorninger reveals how endotoxin exposure from kitty litter led to CIRS and ...
A new study in Scientific Reports reveals that skin shame is a key psychological burden for people with atopic dermatitis and ...
The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...
Cutaneous lupus affects quality of life by limiting social participation and increasing mental health concerns, according to ...
Living with Chronic Spontaneous Urticaria can be challenging, especially when triggers seem ubiquitous. Here's what you need ...
The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.
The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...